Skip to main content
Premium Trial:

Request an Annual Quote

Bright Moves to Rockefeller

Rick Bright, who led the US Biomedical Advanced Research and Development Authority, until last April, has taken on a new role at the Rockefeller Foundation aimed at preventing future pandemics, Science reports.

In a whistleblower complaint last May, Bright alleged that he was forced out of his role at BARDA and into a smaller role at the National Institutes of Health because he was pushed for stringent testing of chloroquine and hydroxychloroquine, which former President Donald Trump had pushed, with limited evidence, as treatments for COVID-19. He left his position at NIH in October, after further alleging that he had been "deliberately impeded" in his new role. Bright later joined a COVID-19 advisory board convened by then President-elect Joe Biden.

According to the Rockefeller Foundation, Bright is to work with other global public health organizations to establish a pandemic prevention institute that responds quickly to alerts of potential outbreaks to stop their spread.

Science adds that the foundation has also released a report urging the US to boost its genomic surveillance of SARS-CoV-2.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.